Letter: Amphotericin B in astrocytoma

Antimicrobial therapy for intra-abdominal infections: guidelines from the Infectious Disease Advisory Board (IDAB).

Acta chirurgica Belgica·2006

Ventilator-associated pneumonia in a tertiary care ICU: analysis of risk factors for acquisition and mortality.

Acta clinica Belgica·2005

Appropriate and timely empirical antimicrobial treatment of icu infections--a role for carbapenems.

Acta clinica Belgica·2005

Temporal scanner thermometry: a new method of core temperature estimation in ICU patients.

Scottish medical journal·2005

Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality.

Acta clinica Belgica·2005

Infectious complications of acute pancreatitis.

Acta clinica Belgica·2004

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Application of nanotherapy in cardiovascular diseases featuring novel pharmacological mechanisms and drug delivery strategies.

Discover nano·2026

Bovine Milk Exosomes as Natural Cytoprotective Nanoplatforms Against Lead-Induced Toxicity.

Biologics : targets & therapy·2026

Exosome-based nanomedicine for neurological disorders: mechanisms, engineering, and therapeutic potential.

Therapeutic delivery·2026

Recent advances in stimulus-responsive nanomaterials for the treatment of inflammatory bowel disease.

Nanoscale·2026

Enhancing Cancer Patient Outcomes using Theranostic Nanomedicine: Advances, Challenges, and Future Prospects.

Mini reviews in medicinal chemistry·2026

Clinical observation of ultrasound-guided microwave ablation for 1717 benign breast lesions: a multicenter study.

Insights into imaging·2026

Related Experiment Videos

Letter: Amphotericin B in astrocytoma

Related Concept Videos

Antimicrobial therapy for intra-abdominal infections: guidelines from the Infectious Disease Advisory Board (IDAB).

Ventilator-associated pneumonia in a tertiary care ICU: analysis of risk factors for acquisition and mortality.

Appropriate and timely empirical antimicrobial treatment of icu infections--a role for carbapenems.

Temporal scanner thermometry: a new method of core temperature estimation in ICU patients.

Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality.

Infectious complications of acute pancreatitis.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Application of nanotherapy in cardiovascular diseases featuring novel pharmacological mechanisms and drug delivery strategies.

Bovine Milk Exosomes as Natural Cytoprotective Nanoplatforms Against Lead-Induced Toxicity.

Exosome-based nanomedicine for neurological disorders: mechanisms, engineering, and therapeutic potential.

Recent advances in stimulus-responsive nanomaterials for the treatment of inflammatory bowel disease.

Enhancing Cancer Patient Outcomes using Theranostic Nanomedicine: Advances, Challenges, and Future Prospects.

Clinical observation of ultrasound-guided microwave ablation for 1717 benign breast lesions: a multicenter study.

Related Experiment Videos

Letter: Amphotericin B in astrocytoma

Related Concept Videos

Related Articles